IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
28 hedge funds and large institutions have $4.76M invested in ImmunoCellular Therapeutics, Ltd. in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$402K | |
| 2 | +$11.5K | |
| 3 | +$11K | |
| 4 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$10K |
| 5 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
+$5K |
Top Sellers
| 1 | -$715K | |
| 2 | -$219K | |
| 3 | -$145K | |
| 4 |
CC
Callan Capital
La Jolla,
California
|
-$143K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$10.5K |